1. Home
  2. TERN vs AWP Comparison

TERN vs AWP Comparison

Compare TERN & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TERN
  • AWP
  • Stock Information
  • Founded
  • TERN 2017
  • AWP 2007
  • Country
  • TERN United States
  • AWP United States
  • Employees
  • TERN N/A
  • AWP N/A
  • Industry
  • TERN Biotechnology: Pharmaceutical Preparations
  • AWP Trusts Except Educational Religious and Charitable
  • Sector
  • TERN Health Care
  • AWP Finance
  • Exchange
  • TERN Nasdaq
  • AWP Nasdaq
  • Market Cap
  • TERN 382.2M
  • AWP 352.4M
  • IPO Year
  • TERN 2021
  • AWP N/A
  • Fundamental
  • Price
  • TERN $4.43
  • AWP $4.01
  • Analyst Decision
  • TERN Buy
  • AWP
  • Analyst Count
  • TERN 5
  • AWP 0
  • Target Price
  • TERN $18.30
  • AWP N/A
  • AVG Volume (30 Days)
  • TERN 1.9M
  • AWP 331.5K
  • Earning Date
  • TERN 03-13-2025
  • AWP 01-01-0001
  • Dividend Yield
  • TERN N/A
  • AWP 12.48%
  • EPS Growth
  • TERN N/A
  • AWP N/A
  • EPS
  • TERN N/A
  • AWP N/A
  • Revenue
  • TERN N/A
  • AWP N/A
  • Revenue This Year
  • TERN N/A
  • AWP N/A
  • Revenue Next Year
  • TERN N/A
  • AWP N/A
  • P/E Ratio
  • TERN N/A
  • AWP N/A
  • Revenue Growth
  • TERN N/A
  • AWP N/A
  • 52 Week Low
  • TERN $4.32
  • AWP $3.06
  • 52 Week High
  • TERN $11.40
  • AWP $4.20
  • Technical
  • Relative Strength Index (RSI)
  • TERN 26.46
  • AWP 54.76
  • Support Level
  • TERN $4.56
  • AWP $3.68
  • Resistance Level
  • TERN $5.95
  • AWP $4.01
  • Average True Range (ATR)
  • TERN 0.29
  • AWP 0.09
  • MACD
  • TERN -0.10
  • AWP 0.03
  • Stochastic Oscillator
  • TERN 3.17
  • AWP 100.00

About TERN Terns Pharmaceuticals Inc.

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.

About AWP abrdn Global Premier Properties Fund of Beneficial Interest

Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.

Share on Social Networks: